NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Emerging-Market Equities Post Best Month Since 2022 Amid AI Optimism and Oil Supply Shock

Emerging-market equities recorded their best month since 2022 in April, driven by rallies in Asian technology shares fueled by optimism over artificial intelligence demand. This comes despite ongoing concerns about an oil supply shock due to the US-Iran standoff over the Strait of Hormuz.

According to MSCI, the index for emerging equities gained 14.5% in April, reversing losses that followed the start of the war. Before a technical index adjustment at the end of the day, the gauge was on track to notch the best monthly rise in 17 years.

The climb reflects more than just a short-covering rally, with analysts predicting further upside. Global X Management's senior portfolio manager, Malcolm Dorson, notes that emerging-market companies have seen profit forecasts lifted by 30% this year, outpacing the average 10% upgrade for the S&P 500.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Risk sentiment was mixed on Thursday, with developing-nation stocks sliding 1.1% as most individual currencies gained against a weaker dollar. Despite crude prices retreating from four-year highs, they held well above $110 a barrel, and fears remain that the Iran conflict is set to escalate. The Axios report that US President Donald Trump is set to receive a briefing on new military options for action, while Iran's new supreme leader vowed to guard the country's nuclear and missile technologies, has heightened market concerns.

MarketApril Change
MSCI Emerging Markets Index14.5%
S&P 50010%
Emerging Market Companies Profit Forecast Upgrade30%

The latest setback suggests a reckoning for those betting that the war in Iran was winding down and the oil-price shock would be limited. It's redrawing the lines even more acutely across emerging markets, according to Anthony Kettle, senior portfolio manager at RBC Bluebay Asset Management.

A group of Asian currencies from oil-importing nations, including the Malaysian ringgit, Indonesian rupiah, Taiwanese dollar, and Indian rupee, have borne heavy losses, slipping further on Thursday. The benchmark for EM currencies slipped 0.1%.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

JPMorgan Chase & Co. strategists have slashed their bullish stance on emerging markets currencies to marketweight, citing high valuations and positioning in foreign exchanges, as well as increasing stagflationary risks. They turned bearish on Asia currencies and remain overweight in higher-yielding names in Latin America and Eastern Europe, Middle East and Africa.

Colombia's central bank unexpectedly halted a series of interest rate increases that had provoked a bitter clash with the government, leaving the key rate at 11.25% in a unanimous decision. The Romanian leu fell 1.8% against the euro as a government crisis escalated.

Investor Takeaway

Emerging-market equities may continue to show upside due to increased demand for artificial intelligence.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.